摘要
中国科学家因在特殊年代研发的青蒿素而获得诺贝尔奖,引发了对我国新时代生物医学科研管理策略的探讨.科学研究已进入大科学时代,对传统的科研管理模式提出了挑战.剑桥大学的生物医学成果显著,其科研管理体系较为完善,本文在介绍其科研管理经验的基础上,结合我国现状提出了相关建议.
In China,the Chinese scientist TU Youyou,winner of the Nobel Prize in Physiology or Medicine and her findings of artemisinin discovered during the 1970s triggered a lot of discussion on developing a biomedical research management strategy in the new era.Traditional management has faced many challenges in the era of Big Science.The University of Cambridge has remarkable achievements in biomedical research and set up an effective management system.Based on the introduction and observations from Cambridge,this article proposes strategies for advancing research management in Chinese universities in our own context.
作者
陈琦
黎润红
Chen Qi Li Runhong.(Institute for Medical Humanities, Peking University, Beijing 100191, P. R. China)
出处
《中华医学科研管理杂志》
2017年第1期2-5,20,共5页
Chinese Journal of Medical Science Research Management
基金
国家留学基金(CSCNO.201406015022)
国家社科基金项目(12BGL114)
关键词
剑桥大学
生物医学
科研管理
University of Cambridge
Biomedicine
Research management